Forensic scientists use postmortem imaging-guided biopsy to determine natural causes of death

Oct 21, 2010

Researchers found that the combination of computed tomography (CT), postmortem CT angiography (CTA) and biopsy can serve as a minimally invasive option for determining natural causes of death such as cardiac arrest, according to a study in the November issue of the American Journal of Roentgenology.

In the last decade, postmortem imaging, especially CT, has gained increasing acceptance in the forensic field. However, CT has certain limitations in the assessment of natural death.

"Vascular and organ pathologic abnormalities, for example, generally cannot be visualized accurately using native CT scans. To address the problem of these abnormalities, postmortem angiography has been implemented with great success," said Stephan A. Bolliger, MD, lead author of the study.

Researchers from the Institute of Forensic Medicine, Centre for Forensic Imaging and Virtopsy, at the University of Bern in Bern, Switzerland, examined 20 bodies in a minimally invasive fashion using CT, CTA and biopsy and compared the results to those obtained at subsequent autopsy. Results showed that the minimally invasive examination showed almost identical results in 18 of 20 cases.

"The combination of CT, postmortem CTA and is a valid tool to examine bodies in a minimally invasive fashion. However, a close collaboration between pathologists and radiologists is imperative for the correct sampling and diagnostic assessment and, therefore, for the success of such an undertaking," said Bolliger.

Explore further: New research demonstrates benefits of national and international device registries

More information: www.ajronline.org/

Provided by American College of Radiology

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.